The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.853, 93.865, 93.866, 93.867 |
PAR-20-111 |
| Partnerships for the Development of Universal Influenza Vaccines (R21/R33 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-003 |
| National Longitudinal Study of Adolescent to Adult Health (Add Health) Wave 6 (U01 Clinical Trial Not Allowed) |
93.275, 93.307, 93.865, 93.866 |
RFA-AG-21-008 |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U19 Clinical Trial Optional) |
93.242, 93.273, 93.279 |
PAR-20-119 |
| Multidisciplinary Studies to Improve Understanding of Influenza Transmission (U19 Clinical Trial Optional) |
93.855 |
RFA-AI-20-008 |
| Alzheimers Disease Sequencing Project Functional Genomics Consortium (U01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-006 |
| Limited Competition: Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 Clinical Trial Not Allowed) |
93.307 |
RFA-MD-20-007 |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional) |
93.242, 93.273, 93.279 |
PAR-20-118 |
| Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-009 |
| BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-20-128 |
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) |
93.394, 93.395 |
PAR-20-116 |
| Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional) |
93.866 |
RFA-AG-21-016 |
| Exploring the Roles of Biomolecular Condensates (BMCs) in HIV replication, latency, or pathogenesis in the context of substance use disorders (R21/R33 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-21-004 |
| Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-019 |
| Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional) |
93.859 |
PAR-20-117 |
| Contraceptive Development Research Centers (CDRC) Program (P50 Clinical Trial Optional) |
93.865 |
RFA-HD-21-011 |
| Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional) |
93.859 |
PAR-20-115 |
| Implementing the HIV Service Cascade for Justice-Involved Populations (U01 Clinical Trial Required) |
93.279 |
RFA-DA-20-028 |
| Network for Identification, Evaluation, and Tracking of Older Persons with Superior Cognitive Performance for Their Chronological Age (U19 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-015 |
| Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) |
93.351, 93.859 |
PAR-20-113 |
| High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) |
93.351, 93.859 |
PAR-20-114 |
| Vaccine and Treatment Evaluation Units (VTEUs): Enhancing Capability and Capacity (UM1 Clinical Trial Required) |
93.855 |
RFA-AI-20-021 |
| Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed) |
93.351 |
PAR-20-112 |
| Training Modules to Enhance the Rigor, Reproducibility and Responsible Conduct of Biomedical Data Science Research (R25 - Clinical Trial Not Allowed) |
93.121, 93.213, 93.286, 93.855, 93.859, 93.879 |
RFA-GM-20-001 |
| Prodromal Synucleinopathies Consortium (U19 Clinical Trial Optional) |
93.853, 93.866 |
RFA-AG-21-013 |
| Optimizing Natural Systems for Remediation: Utilizing Innovative Materials Science Approaches to Enhance Bioremediation (R01 Clinical Trial Not Allowed) |
93.143 |
RFA-ES-20-004 |
| Limited Competition: Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Centers (U42) |
93.351 |
RFA-OD-20-012 |
| Research Centers in Minority Institutions (RCMI) (U54)- Clinical Trials Optional |
93.307 |
RFA-MD-20-006 |
| Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed) |
93.853 |
RFA-NS-20-016 |
| Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required) |
93.077 |
RFA-OD-20-011 |
| Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required) |
93.077 |
RFA-OD-20-010 |
| National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (U24 Clinical Trial Not Allowed) |
93.866 |
PAR-20-110 |
| Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed) |
93.077 |
RFA-OD-20-009 |
| Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed) |
93.077 |
RFA-OD-20-008 |
| Reducing Stigma at Systems, Organizational, and Individual Client Levels in the Ryan White HIV/AIDS Program |
93.145 |
HRSA-20-112 |
| Molecular Mechanisms of Combination Adjuvants (MMCA) (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-004 |
| Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed) |
93.350 |
PAR-20-109 |
| Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed) |
93.350 |
PAR-20-098 |
| Biomedical Technology Development and Dissemination Center (RM1 - Clinical Trial Not Allowed) |
93.859 |
PAR-20-104 |
| International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) |
93.855 |
PAR-20-108 |
Search Results 2961-3000 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
